Tulsa Surgical Arts • Board Certified by the American Board of Cosmetic Surgery • 7322 E 91st Street • Tulsa, OKlahoma 74133

Angelo Cuzalina, MD

FDA Panel Votes to Expand Indications for Restylane

Approved FDA indications for Restylane may soon be expanded to include lip augmentation, according to a recent press release from Medicis Pharmaceutical.

An advisory panel on cosmetic surgery devices voted to expand approved indications for the popular wrinkle filler, which could allow Restylane to be marketed for lip augmentation purposes.

Jonah Shacknai, CEO and Chairman of Medicis, says his company is “pleased with the panel’s recommendation,” and they believe the recommendation “reflects confidence in the robust clinical data provided by Medicis.”

Restylane is already approved for non-surgical correction of facial wrinkles – typically the nasolabial folds on each side of the mouth. The filler was one of the first hyaluronic acid based products to receive FDA approval (in 2004). Expansion of its approved indications would make Restylane the first HA filler approved for lip augmentation.

Restylane is a wrinkle filler made from hyaluronic acid, a naturally occurring substance in the connective tissue of your skin. The product is made with a special form of HA, a non-animal stabilized hyaluronic acid, which restores volume in the tissue. Treatment can address wrinkles and folds to provide a more youthful appearance.






Real Patients, Real Results

View Dr. Cuzalina’s Face, Breast, and Body Before & After Gallery. Dr. Cuzalina’s focus for his patients is to have natural-looking results for all procedures. You can view real results with real patients whose lives Dr. Cuzalina has changed.